An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

A new implantable device provides an alternative treatment for sleep apnea, offering relief to those who struggle with ...

Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

Inspire Medical Systems crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for ...

After announcing a $20 million funding round in June, the startup has set its sights on growing its customer-facing workforce ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” second-quarter 2025 investor letter. A ...

INSP) on Monday reported a loss of $3.6 million in its second quarter. The Golden Valley, Minnesota-based company said it had ...

GAAP revenue for Q2 2025 rose to $217.1 million, up 11% from the prior year and beating expectations. Management reduced full-year 2025 revenue and diluted net income per share guidance due to a ...

Research from UCSF Fresno found a 50-percent drop in sleep quality for women over 50 compared to men in that same age group. Dr. Lourdes DelRosso is one of the authors of the study. "I think this is ...

Investing.com -- Inspire Medical Systems (NYSE: INSP) stock plunged 27% after the company’s disappointing quarterly results and guidance prompted four Wall Street firms to downgrade the shares.

The benchmark Russell 2000® Growth Index gained 11.97% for the period, while the Wasatch Ultra Growth Fund lagged with a ...

For the quarter, the Russell Midcap® Growth Index was up 18.20%, while the Wasatch U.S. Select Fund—Investor Class gained ...